Research papers showing devastating impact of COVID gene injection on innate immune system and neurotoxicity; keep for your libraries; a lead researcher is MIT's Dr. Stephanie Seneff; brilliant!

1)https://pubmed.ncbi.nlm.nih.gov/35436552/
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of
G-quadruplexes, exosomes, and MicroRNAs

2)Seneff, S.; Nigh, G. Worse than the disease? Reviewing some possible
unintended consequences of the mRNA vaccines against COVID-19. IJVTPR
2021; 2(1): 38-79.
https://ijvtpr.com/index.php/IJVTPR/article/view/23

3)Amyloidogenesis of SARS-CoV-2 Spike Protein
This demonstrates prion-like capabilities of the spike protein:
Nydström, S.; Hammarström, P. Amyloidogenesis of SARS-CoV2 spike
protein. J Am Chem Soc 2022; 144: 8945-8950. doi: 10.1021/jacs.2c03925.

This shows upregulation of alpha synuclein and increased risk to
Parkinson's disease:

4)SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro

Wu, Z.; Zhang, X.; Huang, Z., Ma, K. SARS-CoV-2 proteins interact with
alpha synuclein and induce Lewy body-like pathology in vitro. Int J Mol
Sci 2022; 23: 3394. doi: 10.3390/ijms23063394

This is an important paper showing that the spike protein activates toll
like receptor 4, which leads to a strong inflammatory response.

5)SARS-CoV-2 spike protein interacts with and activates TLR41

J.; Yin, H.; Wang, X.; You, F. SARS-CoV-2 spike protein interacts with
and activates TLR41. Cell Research 2021; 31: 818-820. doi:
10.1038/s41422-021-00495-9.

This shows that spike subunit S1 alone is neurotoxic:

6)SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties

Frank, M.G.; Nguyen, K.H.; Ball, J.B.; Hopkins, S.; Kelley, T.; Baratta,
M.V.; Fleshner, M.; Maier, S.F.; SARS-CoV-2 spike S1 subunit induces
neuroinflammatory, microglial and behavioral sickness responses:
Evidence of PAMP-like properties. Brain Behav Immun 2022; 100: 267-277.
doi: 10.1016/j.bbi.2021.12.007.

This shows that spike has a sequence that resembles a toxic enterotoxin
produced by Staph aureus.

7)A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro

Cheng, M.H.; Porritt, R.A.; Rivas, M.N.; Krieger, J.M.; Ozdemir, A.B.;
Garcia, G., Jr.; Arumugaswami, V.; Fries, B.C.; Arditik, M.; Bahar, I. A
monoclonal antibody against staphylococcal enterotoxin B superantigen
inhibits SARS-CoV-2 entry in vitro. Structure 2021; 29(9): 951-962.e3.
doi: 10.1016/j.str.2021.04.005

Shows spike still present 15 months post-infection:

8)Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Patterson, B.K.; Francisco, E.B.; Yogendra, R.; Long, E.; Pise, A.;
Rodrigues, H.; Hall, E.; Herrera, M.; Parikh, P.; Guevara-Coto, J.;
Triche, T.J.; Scott, P.; Hekmati, S.; Maglinte, D.; Chang, X.;
Mora-Rodrguez, R.A.; Mora, J. Persistence of SARS CoV-2 S1 protein in
CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15
months post-infection. Front Immunol 2022; 12: 746021. doi:
10.3389/fimmu.2021.746021

Spike still present several months after vaccination:

9)SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms

Patterson, B.K.; Francisco, E.B.; Yogendra, R.; Long, E.; Pise, A.;
Beaty, C.; Osgood, E.; Bream, J.; Kreimer, M.; Heide, R.V.;
Guevara-Coto, J.; Mora-Rodríguez R.A.; Mora, J. SARS-CoV-2 S1 protein
persistence in SARS-CoV-2 negative post-vaccination individuals with
long COVID/ PASC-like symptoms. Research Square Preprint. Jul 12, 2022.
doi: 10.21203/rs.3.rs-1844677/v1.